Mice Lacking the α4 Nicotinic Receptor Subunit Fail to Modulate Dopaminergic Neuronal Arbors and Possess Impaired Dopamine Transporter Function

Neuronal nicotinic acetylcholine receptors (nAChRs) at presynaptic sites can modulate dopaminergic synaptic transmission by regulating dopamine (DA) release and uptake. Dopaminergic transmission in nigrostriatal and mesolimbic pathways is vital for the coordination of movement and is associated with learning and behavioral reinforcement. We reported recently that the D2 DA receptor plays a central role in regulating the arbor size of substantia nigra dopaminergic neurons. Given the known effects of nAChRs on dopaminergic neurotransmission, we assessed the ability of the α4 nAChR subunit to regulate arbor size of dopaminergic neurons by comparing responses of wild-type and α4 nAChR subunit knockout [α4(-/-)] mice to long-term exposure to cocaine, amphetamine, nicotine, and haloperidol, and after substantia nigra neurotoxic lesioning. We found that dopaminergic neurons in adult drug-naive α4(-/-) mice had significantly larger terminal arbors, and despite normal short-term behavioral responses to drugs acting on pre- and postsynaptic D2 DA receptors, they were unable to modulate their terminal arbor in response to pharmacological manipulation or after lesioning. In addition, although synaptosome DA uptake studies showed that the interaction of the D2 DA receptor and the dopamine transporter (DAT) was preserved in α4(-/-) mice, DAT function was found to be impaired. These findings suggest that the α4 subunit of the nAChR is an independent regulator of terminal arbor size of nigrostriatal dopaminergic neurons and that reduced functionality of presynaptic DAT may contribute to this effect by impairing DA uptake.

[1]  H. J. G. Gundersen,et al.  The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[2]  G. Lunt,et al.  Presynaptic modulation of transmitter release by nicotinic receptors. , 1989, Progress in brain research.

[3]  C V Howard,et al.  The total number of neurons in the human neocortex unbiasedly estimated using optical disectors , 1990, Journal of microscopy.

[4]  J. Changeux,et al.  Immunocytochemical localization of a neuronal nicotinic receptor: the beta 2-subunit , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[5]  P. Clarke,et al.  Blockade of nicotinic receptor‐mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro , 1994, British journal of pharmacology.

[6]  T. Svensson,et al.  Systemic nicotine‐induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area , 1994, Synapse.

[7]  A. Sacaan,et al.  Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. , 1995, The Journal of pharmacology and experimental therapeutics.

[8]  J. Changeux,et al.  Neuronal Nicotinic Receptor a6 Subunit mRNA is Selectively Concentrated in Catecholaminergic Nuclei of the Rat Brain , 1996, The European journal of neuroscience.

[9]  C. Ksir,et al.  Nicotine Effects on Dopamine Clearance in Rat Nucleus Accumbens , 1996, Journal of neurochemistry.

[10]  S. Wonnacott,et al.  Presynaptic Nicotinic Modulation of Dopamine Release in the Three Ascending Pathways Studied by In Vivo Microdialysis: Comparison of Naive and Chronic Nicotine‐Treated Rats , 1997, Journal of neurochemistry.

[11]  J. Changeux,et al.  Identification of Four Classes of Brain Nicotinic Receptors Using β2 Mutant Mice , 1998, The Journal of Neuroscience.

[12]  R. Wightman,et al.  Profound neuronal plasticity in response to inactivation of the dopamine transporter. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Lester,et al.  Regulation of α4β2 Nicotinic Receptor Desensitization by Calcium and Protein Kinase C , 1999 .

[14]  J. Drago,et al.  Late direct and transneuronal effects in mice with targeted expression of a toxin gene to D1 dopamine receptor neurons , 1999, Neuroscience.

[15]  H. Melikian,et al.  Membrane Trafficking Regulates the Activity of the Human Dopamine Transporter , 1999, The Journal of Neuroscience.

[16]  J. Drago,et al.  Early direct and transneuronal effects in mice with targeted expression of a toxin gene to D1 dopamine receptor neurons , 1999, Neuroscience.

[17]  I. Scheffer,et al.  Phenotypic Characterization of an α4 Neuronal Nicotinic Acetylcholine Receptor Subunit Knock-Out Mouse , 2000, The Journal of Neuroscience.

[18]  F. Gonon,et al.  Release and elimination of dopamine in vivo in mice lacking the dopamine transporter: functional consequences , 2000, The European journal of neuroscience.

[19]  N. Volkow,et al.  Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor , 2000, Synapse.

[20]  M. Horne,et al.  Axonal sprouting following lesions of the rat substantia nigra , 2000, Neuroscience.

[21]  S. Wonnacott,et al.  Involvement of protein kinase C in the presynaptic nicotinic modulation of [3H]‐dopamine release from rat striatal synaptosomes , 2001, British journal of pharmacology.

[22]  R. Hen,et al.  Hyperactivity and impaired response habituation in hyperdopaminergic mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Horne,et al.  The role of dopamine receptors in regulating the size of axonal arbors. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  M. Horne,et al.  The Role of Interleukin-1, Interleukin-6, and Glia in Inducing Growth of Neuronal Terminal Arbors in Mice , 2002, The Journal of Neuroscience.

[25]  Anthony Kinsella,et al.  Phenotypic, ethologically based resolution of spontaneous and D2‐like vs D1‐like agonist‐induced behavioural topography in mice with congenic D3 dopamine receptor “knockout” , 2002, Synapse.

[26]  M. Horne,et al.  Effects of long‐term treatment with dopamine receptor agonists and antagonists on terminal arbor size , 2002, The European journal of neuroscience.

[27]  M. Zoli,et al.  Identification of the Nicotinic Receptor Subtypes Expressed on Dopaminergic Terminals in the Rat Striatum , 2002, The Journal of Neuroscience.

[28]  J. Drago,et al.  D2 Dopamine receptor blockade results in sprouting of DA axons in the intact animal but prevents sprouting following nigral lesions , 2003, The European journal of neuroscience.

[29]  I. McGregor,et al.  Increased Anxiety 3 Months after Brief Exposure to MDMA (‘Ecstasy’) in Rats: Association with Altered 5-HT Transporter and Receptor Density , 2003, Neuropsychopharmacology.

[30]  M. Horne,et al.  Neuronal nicotinic receptors: insights gained from gene knockout an knocking mutant mice , 2003, Cellular and Molecular Life Sciences CMLS.

[31]  M. Pacheco,et al.  Phosphorylation of the α4 subunit of human α4β2 nicotinic receptors: role of cAMP-dependent protein kinase (PKA) and protein kinase C (PKC) , 2003 .

[32]  J. Changeux,et al.  Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors , 2003, The European journal of neuroscience.

[33]  M. Horne,et al.  Timecourse of striatal re‐innervation following lesions of dopaminergic SNpc neurons of the rat , 2003, The European journal of neuroscience.

[34]  L. Werling,et al.  Nicotinic receptor-mediated regulation of the dopamine transporter in rat prefrontocortical slices following chronic in vivo administration of nicotine , 2003, Schizophrenia Research.

[35]  J. Waddington,et al.  Congenic D1A Dopamine Receptor Mutants: Ethologically Based Resolution of Behavioural Topography Indicates Genetic Background as a Determinant of Knockout Phenotype , 2003, Neuropsychopharmacology.

[36]  Nicolas Le Novère,et al.  Subunit Composition of Functional Nicotinic Receptors in Dopaminergic Neurons Investigated with Knock-Out Mice , 2003, The Journal of Neuroscience.

[37]  M. Pacheco,et al.  Phosphorylation of the alpha4 subunit of human alpha4beta2 nicotinic receptors: role of cAMP-dependent protein kinase (PKA) and protein kinase C (PKC). , 2003, Brain research. Molecular brain research.

[38]  M. Horne,et al.  Changes in function and ultrastructure of striatal dopaminergic terminals that regenerate following partial lesions of the SNpc. , 2003, Journal of neurochemistry.

[39]  L. Dwoskin,et al.  Nicotinic Receptor Modulation of Dopamine Transporter Function in Rat Striatum and Medial Prefrontal Cortex , 2004, Journal of Pharmacology and Experimental Therapeutics.

[40]  G. Hu,et al.  Activities of cAMP-dependent protein kinase and protein kinase C are modulated by desensitized nicotinic receptors in the rat brain , 2004, Neuroscience Letters.

[41]  A. C. Collins,et al.  Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. , 2004, Molecular pharmacology.

[42]  M. Kim,et al.  Chronic nicotine and smoking treatment increases dopamine transporter mRNA expression in the rat midbrain , 2004, Neuroscience Letters.